Posted by Michael Wonder on 18 Nov 2020
Pfizer will seek regulatory review ‘within days’ for its vaccine
18 November 2020 - The coronavirus vaccine being developed by Pfizer and German biotechnology firm BioNTech is 95% effective at preventing disease, and an application for emergency authorisation will be submitted “within days,” according to a news release from the companies.
The announcement came hours after the FDA authorised the first rapid coronavirus test that can be taken at home and can deliver results within minutes, potentially allowing people to skip long lines at testing sites.
